Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Modulation of μ Opioid Receptor Mediated Analgesia, Tolerance and Hyperalgesia in Children and Adolescents


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01325493

Organisation Name: Children's National Research Institute

Overal Status: Completed

Start Date: January 2010

Last Update: January 14, 2016

Lead Sponsor: Julia Finkel

Brief Summary: The purpose of this study is to:

1. Establish whether ketamine can decrease opioid consumption and modulate the onset of opioid tolerance and prevent opioid-induced hyperalgesia in pediatric subjects, ages 10 years to 18 years, undergoing posterior spinal fusion and instrumentation.

Conditions:
  • Idiopathic Scoliosis
  • Spondylolisthesis


Total execution time in seconds: 0.16461610794067